Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v9-FR Version v7-FR
Language French French
Date Updated 2022-07-06 2022-06-29
Drug Identification Number 02458934 02458934
Brand name MYLAN-DIVALPROEX MYLAN-DIVALPROEX
Common or Proper name DIVALPROEX DIVALPROEX
Company Name MYLAN PHARMACEUTICALS ULC MYLAN PHARMACEUTICALS ULC
Ingredients VALPROIC ACID VALPROIC ACID
Strength(s) 250MG 250MG
Dosage form(s) TABLET (DELAYED-RELEASE) TABLET (ENTERIC-COATED) TABLET (DELAYED-RELEASE) TABLET (ENTERIC-COATED)
Route of administration ORAL ORAL ORAL ORAL
Packaging size 100BT, 500BT 100BT, 500BT
ATC code N03AG N03AG
ATC description ANTIEPILEPTICS ANTIEPILEPTICS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date 2022-06-22 2022-06-22
Actual start date 2022-06-20 2022-06-20
Estimated end date 2022-06-30 2022-06-30
Actual end date 2022-06-30
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments